BIM-23244

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameBIM-23244
Drug Alias NameBIM-23244
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSomatostatin receptor 2 agonistsSomatostatin receptor 5 agonists
TargetsSomatostatin receptor 2Somatostatin receptor 5
Therapy Area/IndicationsAcromegaly
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCentre National De La Recherche Scientifique (Cnrs)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCentre National De La Recherche Scientifique (Cnrs)
Active IndicationsN/A
Inactive IndicationsAcromegaly

Other Information

ATC CodeN/A
Related LinksN/A